Search Results

NycoCard® CRP Test system is an in vitro diagnostic device for the quantification of Creactive protein (CRP) in human serum, plasma, and whole blood by a solid phase, sandwich-format, immunometric assay. The measurement of CRP aids in evaluation of sandwish inflammatory process induced by infectious microbial agents or by noninfectious inflammatory stimuli.

Not Found

This looks like a 510(k) clearance letter for the NycoCard® CRP device, which is an in vitro diagnostic device. This type of document typically declares the device substantially equivalent to a predicate device and allows it to be marketed. However, it does not contain detailed information about the acceptance criteria or a study proving the device meets those criteria, nor does it typically discuss AI or ground truth in the context of device performance studies.

The information provided is primarily regulatory in nature (device name, regulation number, product code, substantial equivalence determination). There is no mention of specific performance metrics, sample sizes for studies, expert involvement, adjudication methods, or AI comparative effectiveness studies.

Therefore, I cannot extract the requested information from the provided text.

Ask a specific question about this device

The NycoCard® CRP Control is an assayed human serum control material intended to monitor and evaluate the precision and accuracy of quantitative C-reactive protein (CRP) assays. It is particularly recommended for use with the NycoCard® CRP point-ofcare test system for determination of C-reactive protein (510(k) submission date November 13. 2001, (K013787, Establishment Registration Number 1931251). Measurement of C-reactive protein aids in evaluation of the amount of injury to body tissue.

Not Found

The provided text is a 510(k) premarket notification letter from the FDA regarding the "NycoCard® CRP Control" device. It is a control material used to monitor the precision and accuracy of C-reactive protein (CRP) assays, particularly with the NycoCard® CRP point-of-care test system.

The document does not contain any information about acceptance criteria or a study proving the device meets acceptance criteria. It is a regulatory approval letter based on substantial equivalence to a predicate device, not a performance study report.

Therefore, I cannot provide the requested information.

Ask a specific question about this device